These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 32037974)

  • 21. Pharmacophore- based virtual screening, 3D- QSAR, molecular docking approach for identification of potential dipeptidyl peptidase IV inhibitors.
    Shah BM; Modi P; Trivedi P
    J Biomol Struct Dyn; 2021 Apr; 39(6):2021-2043. PubMed ID: 32242496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches.
    Jana S; Singh SK
    J Biomol Struct Dyn; 2019 Mar; 37(4):944-965. PubMed ID: 29475408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3D-QSAR, molecular dynamics simulations and molecular docking studies of benzoxazepine moiety as mTOR inhibitor for the treatment of lung cancer.
    Chaube U; Chhatbar D; Bhatt H
    Bioorg Med Chem Lett; 2016 Feb; 26(3):864-874. PubMed ID: 26764189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2
    Musoev A; Numonov S; You Z; Gao H
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A combination of pharmacophore modeling, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on PDE4 enzyme inhibitors.
    Tripuraneni NS; Azam MA
    J Biomol Struct Dyn; 2016 Nov; 34(11):2481-92. PubMed ID: 26587754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening of inhibitors as potential remedial against Ebolavirus infection: pharmacophore-based approach.
    Sankar M; K L; Jeyachandran S; Pandi B
    J Biomol Struct Dyn; 2021 Feb; 39(2):395-408. PubMed ID: 31928158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular modelling studies on adamantane-based Ebola virus GP-1 inhibitors using docking, pharmacophore and 3D-QSAR.
    Mali SN; Chaudhari HK
    SAR QSAR Environ Res; 2019 Mar; 30(3):161-180. PubMed ID: 30786763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive models for designing potent tyrosine kinase inhibitors in chronic myeloid leukemia for understanding its molecular mechanism of resistance by molecular docking and dynamics simulations.
    Melge AR; Kumar LG; K P; Nair SV; K M; C GM
    J Biomol Struct Dyn; 2019 Nov; 37(18):4747-4766. PubMed ID: 30580670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacophore-based virtual screening of ZINC database, molecular modeling and designing new derivatives as potential HDAC6 inhibitors.
    Poonia P; Sharma M; Jha P; Chopra M
    Mol Divers; 2023 Oct; 27(5):2053-2071. PubMed ID: 36214962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting the NF-κB/IκBα complex via fragment-based E-Pharmacophore virtual screening and binary QSAR models.
    Kanan T; Kanan D; Erol I; Yazdi S; Stein M; Durdagi S
    J Mol Graph Model; 2019 Jan; 86():264-277. PubMed ID: 30415122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of potential Aurora-A kinase inhibitors by 3D QSAR pharmacophore modeling, virtual screening, docking, and MD simulation studies.
    Swamy P M G; Abbas N; Dhiwar PS; Singh E; Ghara A; Das A
    J Biomol Struct Dyn; 2023 Jan; 41(1):125-146. PubMed ID: 34809538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consensus scoring model for the molecular docking study of mTOR kinase inhibitor.
    Li DD; Meng XF; Wang Q; Yu P; Zhao LG; Zhang ZP; Wang ZZ; Xiao W
    J Mol Graph Model; 2018 Jan; 79():81-87. PubMed ID: 29154212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacophore Based 3D-QSAR, Virtual Screening and Docking Studies on Novel Series of HDAC Inhibitors with Thiophen Linker as Anticancer Agents.
    Patel P; Singh A; Patel VK; Jain DK; Veerasamy R; Rajak H
    Comb Chem High Throughput Screen; 2016; 19(9):735-751. PubMed ID: 27487787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-throughput virtual screening of phenylpyrimidine derivatives as selective JAK3 antagonists using computational methods.
    Faris A; Ibrahim IM; Hadni H; Elhallaoui M
    J Biomol Struct Dyn; 2024 Sep; 42(14):7574-7599. PubMed ID: 37539779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A computational investigation of thymidylate synthase inhibitors through a combined approach of 3D-QSAR and pharmacophore modelling.
    Benny S; Rajappan Krishnendu P; Kumar S; Bhaskar V; Manisha DS; Abdelgawad MA; Ghoneim MM; Naguib IA; Pappachen LK; Mary Zachariah S; Mathew B; Tp A
    J Biomol Struct Dyn; 2024 Oct; 42(16):8473-8492. PubMed ID: 37870113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Field-based 3D-QSAR for tyrosine protein kinase JAK-2 inhibitors.
    Andole S; Thumma G; Alavala RR; Gangarapu K
    J Biomol Struct Dyn; 2024 Jul; 42(10):5321-5333. PubMed ID: 37409931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined pharmacophore modeling, 3D-QSAR and docking studies to identify novel HDAC inhibitors using drug repurposing.
    Liu J; Zhu Y; He Y; Zhu H; Gao Y; Li Z; Zhu J; Sun X; Fang F; Wen H; Li W
    J Biomol Struct Dyn; 2020 Feb; 38(2):533-547. PubMed ID: 30938574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ligand-based 3-D pharmacophore generation and molecular docking of mTOR kinase inhibitors.
    Tanneeru K; Guruprasad L
    J Mol Model; 2012 Apr; 18(4):1611-24. PubMed ID: 21805127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring novel and potent molecules for disrupting DEPTOR-mTOR interaction through structure-steered screening, extra-exactitude molecular docking, prime binding free energy estimation and voguish molecular dynamics.
    Shah BA; Ganai SA; Koul AM; Mohan S; Amin A; Wani Z; Majeed U; Rajamanikandan S; Farooq F; Malik FA; Shah NN; Qadri RA
    J Biomol Struct Dyn; 2022; 40(22):12037-12047. PubMed ID: 34431457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ligand-based pharmacophore modelling and virtual screening for the identification of amyloid-beta diagnostic molecules.
    Marondedze EF; Govender KK; Govender PP
    J Mol Graph Model; 2020 Dec; 101():107711. PubMed ID: 32898834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.